Additionally, deeper dyspareunia and moderate to severe dysmenorrhoea were predicted by a higher expression of Erα; this suggests that in addition to circulating estrogens, tissue expression of ERα is also associated with the severity of the symptoms [62]. The gene discussed is ESR1; the disease is Dysmenorrhea.